M&A Deal Summary

BELLUS Health Acquires Thallion Pharmaceuticals

On August 15, 2013, BELLUS Health acquired medical products company Thallion Pharmaceuticals

Acquisition Highlights
  • This is BELLUS Health’s 1st transaction in the Medical Products sector.
  • This is BELLUS Health’s 1st transaction in Canada.
  • This is BELLUS Health’s 1st transaction in Quebec.

M&A Deal Summary
Date 2013-08-15
Target Thallion Pharmaceuticals
Sector Medical Products
Buyer(s) BELLUS Health
Deal Type Add-on Acquisition
Advisor(s) Bloom Burton & Co. (Financial)

Target

Thallion Pharmaceuticals

Dorval, Quebec, Canada
Thallion Pharmaceuticals Inc. (TSX: TLN) is a biotechnology company developing pharmaceutical products in the areas of infectious disease and oncology.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

BELLUS Health

Laval, Quebec, Canada
Category Company
Founded 1993
Sector Life Science
Employees32
Revenue 1M USD (2016)
DESCRIPTION

BELLUS Health is developing drugs for rare diseases with a particular focus on renal disorders. The company also has an agreement with AmorChem Holdings Inc. to develop drug candidates for the treatment of AL amyloidosis. BELLUS Health was founded in 1993 and is based in Laval, Canada.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Quebec) 1 of 1
Country (Canada) 1 of 1
Year (2013) 1 of 1
Mergr

Product

Company

Legal